These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15687699)

  • 1. Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling.
    Ye Y; Qiu TH; Kavanaugh C; Green JE
    Breast Dis; 2004; 19():69-82. PubMed ID: 15687699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
    Elias EV; de Castro NP; Pineda PH; Abuázar CS; Bueno de Toledo Osorio CA; Pinilla MG; da Silva SD; Camargo AA; Silva WA; E Ferreira EN; Brentani HP; Carraro DM
    Oncotarget; 2016 Nov; 7(46):75672-75684. PubMed ID: 27708222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
    BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy.
    Kothari C; Ouellette G; Labrie Y; Jacob S; Diorio C; Durocher F
    Oncotarget; 2018 Dec; 9(100):37407-37420. PubMed ID: 30647841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
    Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
    Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
    Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
    BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.
    Cai Y; Nogales-Cadenas R; Zhang Q; Lin JR; Zhang W; O'Brien K; Montagna C; Zhang ZD
    BMC Genomics; 2017 Feb; 18(1):185. PubMed ID: 28212608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
    O'Connell P; Pekkel V; Fuqua SA; Osborne CK; Clark GM; Allred DC
    J Natl Cancer Inst; 1998 May; 90(9):697-703. PubMed ID: 9586667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
    Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
    Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
    Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
    Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.
    Umekita Y; Yoshida H
    Pathol Int; 2000 Jul; 50(7):527-30. PubMed ID: 10886733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.